CONMED CORPORATION (CNMD) FY2026 YTD Q2 P&L / Income Statement

CONMED CORPORATION (CNMD) FY2026 YTD Q2 P&L / Income Statement

Income statement for 2026-01-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net sales

660,534,000 US dollars

Cost of sales

279,629,000 US dollars

Gross profit

380,905,000 US dollars

  Operating expenses

319,085,000 US dollars

Income from operations

61,820,000 US dollars

Other income (expense), net (calculated)

negative 12,118,000 US dollars

Income before income taxes

49,702,000 US dollars

Provision for income taxes

12,803,000 US dollars

Net income

36,899,000 US dollars

Orthopedic Surgery

299,978,000 US dollars

General Surgery

360,556,000 US dollars

Selling and administrative expense

287,252,000 US dollars

Research and development expense

31,833,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.